Clinical Trial Update: Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a single dose of pretomanid added to an optimized background regimen in children with rifampicin-resistant tuberculosis; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rifampicin-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• Pretomanid (pretomanid)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis, Rifampicin Resistant Tuberculosis | Phase 1 | Status: RECRUITING